TrialBMJ (Clinical research ed.)2025

Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.

Yin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.